O'Brian C A, Housey G M, Weinstein I B
Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University, New York, New York 10032.
Cancer Res. 1988 Jul 1;48(13):3626-9.
We have previously demonstrated that tamoxifen and related triphenylethylene compounds are potent inhibitors of protein kinase C (PKC). The present study demonstrates that PKC binds specifically and reversibly to the antiestrogen N-didesmethyltamoxifen when the drug is coupled to CNBr-activated agarose through its primary amine, in the absence of lipid and other cofactors of the enzyme. PKC did not bind to 4-hydroxytamoxifen, which had been immobilized on epoxy-activated Sepharose through its hydroxyl moiety. This shows that the binding of PKC to immobilized N-didesmethyltamoxifen was not merely due to hydrophobic interactions, since N-didesmethyltamoxifen and 4-hydroxytamoxifen have nearly identical hydrophobicities. These results demonstrate that PKC has specific triphenylethylene-binding sites, which may mediate the inhibition of PKC activity by these antiestrogens.
我们之前已经证明,他莫昔芬及相关的三苯乙烯化合物是蛋白激酶C(PKC)的强效抑制剂。本研究表明,当药物通过其伯胺与溴化氰活化琼脂糖偶联时,在没有脂质和该酶的其他辅因子的情况下,PKC能特异性且可逆地结合抗雌激素N-去二甲基他莫昔芬。PKC不与通过其羟基部分固定在环氧活化琼脂糖上的4-羟基他莫昔芬结合。这表明PKC与固定化的N-去二甲基他莫昔芬的结合不仅仅是由于疏水相互作用,因为N-去二甲基他莫昔芬和4-羟基他莫昔芬具有几乎相同的疏水性。这些结果表明,PKC具有特定的三苯乙烯结合位点,这可能介导了这些抗雌激素对PKC活性的抑制作用。